Understanding musculoskeletal health in adult survivors of blood cancers
Musculoskeletal Health in Adult Haematoloigcal Cancer Survivors - a Mixed Methods Study
This study looks at how adult survivors of blood cancers like lymphoma and leukemia deal with muscle and bone problems after treatment to better understand their long-term health challenges.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 650 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | The Christie NHS Foundation Trust Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Manchester) |
| Trial ID | NCT05865678 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on adult survivors of haematological cancers, such as lymphoma and leukemia, to assess the musculoskeletal complications they experience post-treatment. It employs a two-part approach, utilizing questionnaires and interviews to gather data on the extent of musculoskeletal issues and their impact on quality of life. The study aims to fill the gap in understanding how these complications affect survivors, particularly in terms of bone health and the risk of fractures. By capturing patient perspectives, the research seeks to provide valuable insights into their long-term health challenges.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18 and above who have survived lymphoma or leukemia and are not currently undergoing active cancer treatment.
Not a fit: Patients who are currently receiving active cancer treatment will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved management strategies for musculoskeletal health in cancer survivors, enhancing their quality of life.
How similar studies have performed: While there is limited evidence on the specific musculoskeletal complications in this population, similar studies have highlighted the importance of addressing long-term health issues in cancer survivors.
Eligibility criteria
Show full inclusion / exclusion criteria
Questionnaire study Inclusion Criteria: 1. Age 18 or above at diagnosis of haematological cancer 2. Diagnosis of haematological cancers: lymphoma or leukaemia 3. Cancer survivors as recorded in the local database of lymphoma and haematopoietic stem cell transplant database 4. Able to give written informed consent 5. Able to read and understand English Exclusion Criteria: 1.Currently receiving any active cancer treatment Interview study Inclusion Criteria: 1. Age 18 or above at diagnosis of haematological cancer 2. Diagnosis of haematological cancers: lymphoma or leukaemia 3. Cancer survivors as recorded in the local database of lymphoma and haematopoietic stem cell transplant database 4. Able to give written or verbal informed consent 5. Able to read and understand English Exclusion Criteria: 1 .Currently receiving any active cancer treatment
Where this trial is running
Manchester
- The Christie NHS Foundation Trust — Manchester, United Kingdom (Recruiting)
Study contacts
- Study coordinator: Salina Tsui, MSc
- Email: salina.tsui@nhs.net
- Phone: +44 7726781196
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.